enVVeno Medical Corporation (NVNO) Capital expenditures 2017–2025
enVVeno Medical Corporation (NVNO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5,000FY2025 · since FY2017: $10,938 → $5,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5,000 | -86.5% |
| FY2024 | $37,000 | +12.1% |
| FY2023 | $33,000 | -71.3% |
| FY2022 | $115,000 | -68.8% |
| FY2021 | $368,000 | +104.1% |
| FY2020 | $180,291 | -50.5% |
| FY2019 | $363,891 | +2829.4% |
| FY2018 | $12,422 | +13.6% |
| FY2017 | $10,938 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice